Pulmonary Function Testing Market Size, Share & Trends Analysis Report By Product (Portable PFT Systems, Complete PFT Systems, Other), By Applications (Hospitals, Physical Examination Center, Physician Groups, Others), By End Use, By Region, and Segment Forecasts - 2035

Pulmonary Function Testing Market Overview

The pulmonary function testing market was valued at USD 433.45 million in 2025, The market is set to reach USD 451.65 million by 2026-end and grow at a CAGR of 4.2% between 2026-2035 to reach USD 510.99 million by 2035.

The Pulmonary Function Testing Market is expanding as healthcare systems place greater emphasis on objective respiratory assessment, early identification of airflow limitation, chronic disease monitoring, preoperative evaluation, occupational screening, and long-term pulmonary management. Complete PFT Systems are estimated to account for approximately 58.4% of product demand in 2026 because hospitals and specialist respiratory centers require comprehensive measurement of spirometry, lung volumes, diffusion capacity, airway resistance, and related pulmonary parameters. Portable PFT Systems represent approximately 36.7% of product demand and are gaining importance as testing expands beyond conventional pulmonary laboratories. Hospitals remain the largest application category with approximately 47.8% of market demand, supported by substantial patient throughput and established respiratory departments. Modern systems increasingly integrate digital data capture, automated quality checks, electronic medical record connectivity, and guided testing workflows. Diagnostic laboratories are also adopting systems capable of completing standard spirometry assessments within approximately 15 minutes, improving throughput and allowing more patients to be evaluated during routine clinical schedules.

The United States remains a major national market for pulmonary function testing because of its extensive hospital infrastructure, large population requiring respiratory assessment, high adoption of digital diagnostics, and broad availability of specialist pulmonary services. The U.S. is estimated to account for approximately 74.6% of North American demand in 2026. Hospitals represent nearly 49.3% of national PFT utilization, while Physician Groups contribute approximately 21.8% as outpatient pulmonary and primary-care organizations increase access to office-based spirometry. Portable PFT Systems are estimated to represent approximately 38.5% of U.S. equipment demand, supported by decentralized diagnostics, occupational health testing, and outpatient monitoring. Advanced systems can record more than 8 pulmonary parameters within a single diagnostic session and increasingly incorporate automated coaching and quality-control functions. The shift toward preventive respiratory care and earlier disease detection is expected to strengthen U.S. adoption through 2035.

• 

  Download Free sample to learn more about this report.

Key Findings

• Leading Product Type: Complete PFT Systems are expected to hold approximately 58.4% market share in 2026, supported by demand for comprehensive spirometry, diffusion testing, lung-volume assessment, airway resistance measurement, and integrated respiratory diagnostics.
• Leading Application: Hospitals are projected to account for approximately 47.8% of total demand in 2026 because high patient volumes, specialist pulmonology departments, and centralized diagnostic infrastructure support extensive pulmonary testing utilization.
• Leading Region: North America is expected to represent approximately 37.2% of global demand in 2026, supported by mature healthcare infrastructure, high testing penetration, specialist respiratory care, and rapid adoption of digital diagnostic systems.
• Fastest Growing Region: Asia-Pacific is projected to record approximately 5.8% annual growth through 2035 as respiratory screening, hospital capacity, outpatient diagnostics, and portable testing adoption expand across major healthcare markets.
• Technology Trend: Digital PFT platforms increasingly automate quality checks across more than 6 spirometry parameters, improving test reproducibility, reducing technician variability, and supporting integration with electronic health records and remote clinical workflows.
• Market Driver: Rising respiratory disease screening remains a key demand catalyst, with approximately 30% of routine pulmonary evaluations increasingly involving standardized spirometry before additional lung-function measurements are considered.
• Competitive Landscape: The 5 leading suppliers are estimated to influence approximately 48.6% of organized equipment demand through product upgrades, software integration, portable testing development, service networks, and specialist respiratory diagnostic portfolios.
• Future Outlook: Portable PFT Systems are projected to approach approximately 41.5% of product demand by 2035 as outpatient testing, community screening, decentralized diagnostics, and compact respiratory assessment technologies gain wider adoption.

Latest Trends

Digitalization is one of the most important trends reshaping the Pulmonary Function Testing Market. Newer PFT platforms increasingly combine spirometry, lung-volume assessment, diffusion testing, respiratory pressure measurements, and automated quality assurance within unified software environments. Complete PFT Systems can evaluate more than 8 respiratory parameters during comprehensive laboratory testing, reducing the need to operate several disconnected diagnostic instruments. Automated software now assists technicians by identifying questionable effort, incomplete exhalation, poor repeatability, and inconsistent maneuver quality. Spirometry testing can often be completed in approximately 15 minutes when patient cooperation is adequate, enabling higher throughput in hospitals and outpatient respiratory clinics. Electronic medical record integration is also becoming more important because healthcare providers increasingly require test results to transfer directly into longitudinal patient records. These developments are shifting purchasing decisions toward platforms that combine diagnostic capability, software interoperability, workflow automation, and data-management functionality.

Portable pulmonary function testing represents a second major trend as respiratory diagnostics move closer to patients. Portable PFT Systems account for approximately 36.7% of product demand in 2026 and are increasingly used in Physician Groups, Physical Examination Center settings, occupational health programs, outpatient clinics, and decentralized screening environments. Compact systems weighing below 5 kilograms can support rapid movement between examination rooms and community testing locations. Wireless connectivity, tablet-based interfaces, cloud data transfer, and disposable flow sensors are improving practical usability. Portable platforms are also expanding access in regions where dedicated pulmonary laboratories remain limited. Through 2035, the segment is projected to approach approximately 41.5% of product demand as healthcare providers prioritize flexibility and lower infrastructure requirements. This trend is encouraging manufacturers to combine laboratory-grade measurement precision with smaller footprints, simplified calibration, and faster patient setup.

Market Dynamics

Driver

""Growing respiratory screening is increasing demand for objective pulmonary assessment.""

The strongest driver of the Pulmonary Function Testing Market is the expanding need for standardized assessment of respiratory function across chronic disease management, preoperative testing, occupational medicine, pulmonary rehabilitation, and general clinical screening. Hospitals account for approximately 47.8% of market demand in 2026 because comprehensive respiratory testing is commonly concentrated in centralized pulmonary laboratories. Spirometry is frequently the first-line physiological assessment because it measures forced expiratory volume, forced vital capacity, and related airflow indicators within a relatively short examination. Standard spirometry can often be completed within approximately 15 minutes, allowing hospitals to incorporate testing into routine outpatient and inpatient pathways. Complete PFT Systems are particularly important where clinicians need additional measurements such as total lung capacity, residual volume, and diffusion capacity. Increasing use of objective physiological data is improving diagnostic confidence and supporting more personalized treatment monitoring.

Outpatient respiratory diagnostics are also strengthening demand. Physician Groups are estimated to account for approximately 20.7% of market utilization in 2026 as more pulmonary and primary-care practices incorporate office-based testing. Portable PFT Systems enable clinicians to perform diagnostic measurements without referring every patient to a hospital laboratory, improving convenience and potentially shortening the diagnostic pathway. Physical Examination Center applications represent approximately 18.6% of demand and benefit from occupational screening, preventive medical examinations, and respiratory fitness assessment. Systems capable of completing more than 20 tests during a standard clinical working day can materially improve utilization economics for high-volume facilities. Growing emphasis on early intervention and chronic respiratory monitoring is therefore increasing demand for both Complete PFT Systems and portable devices across multiple care settings.

Restraint

""Capital requirements and skilled-operator dependence constrain wider testing adoption.""

High equipment complexity remains an important restraint, particularly for Complete PFT Systems used in comprehensive pulmonary laboratories. These systems require dedicated space, trained personnel, regular calibration, infection-control procedures, and ongoing software maintenance. A comprehensive testing setup may incorporate more than 5 measurement modules, increasing installation and service requirements compared with basic spirometry. Smaller hospitals and Physician Groups may find it difficult to justify investment when patient volumes are insufficient to support frequent utilization. Technician training also influences test quality because patient coaching, maneuver acceptability, calibration verification, and interpretation of repeatability criteria require practical expertise. Even an equipment system with advanced automation can produce unreliable results when the patient performs fewer than 3 acceptable maneuvers or when quality criteria are not followed consistently.

Testing reproducibility presents another restraint because pulmonary function measurements depend substantially on patient effort and cooperation. Spirometry requires forceful inhalation and exhalation, and inadequate technique can affect reported values. Repeat testing may be necessary when variation between acceptable maneuvers exceeds approximately 150 milliliters for key spirometric measurements. Elderly patients, very young individuals, acutely unwell patients, and those with cognitive limitations may find testing particularly challenging. Infection-control requirements also increase operating complexity because mouthpieces, filters, tubing, and reusable components must be managed carefully between patients. Facilities conducting more than 25 tests daily require disciplined workflow to prevent delays. These operational requirements can reduce adoption in lower-resource clinics despite the recognized diagnostic value of pulmonary testing.

Opportunity

""Portable diagnostics and emerging healthcare systems create new expansion potential.""

Portable PFT Systems create a significant market opportunity as healthcare delivery becomes more decentralized. The segment accounts for approximately 36.7% of product demand in 2026 and is projected to reach approximately 41.5% by 2035. Compact devices can support screening at Physician Groups, Physical Examination Center settings, community clinics, rehabilitation centers, and temporary medical facilities. Systems weighing less than 5 kilograms reduce infrastructure requirements and simplify transportation between clinical locations. Wireless connectivity and digital storage also enable test results to be transferred to specialist physicians for review. These capabilities are especially valuable in regions where access to full pulmonary laboratories is limited. Manufacturers that combine portability with automated quality assessment and strong measurement repeatability can address a broad range of outpatient respiratory testing needs.

Asia-Pacific represents another substantial opportunity and is projected to expand at approximately 5.8% annually through 2035. China, India, Japan, South Korea, and other regional markets are investing in hospital capacity, medical diagnostics, and chronic disease management. Portable PFT Systems are particularly relevant where healthcare infrastructure must serve large populations across geographically dispersed areas. Regional Physical Examination Center demand is also increasing as preventive medical screening and occupational health programs expand. A portable device capable of completing approximately 4 tests per hour can support efficient screening without requiring a permanent pulmonary laboratory. Local manufacturing, distributor partnerships, multilingual software, and service networks will be increasingly important for suppliers seeking stronger Asia-Pacific penetration.

Challenge

""Ensuring consistent test quality across decentralized settings remains difficult.""

Maintaining measurement consistency is one of the most important challenges as pulmonary testing expands beyond specialist laboratories. Complete PFT Systems operated by trained respiratory technicians generally benefit from controlled testing environments, whereas portable systems may be used by clinicians with varying levels of respiratory-testing experience. Spirometry quality depends on patient coaching, equipment calibration, test positioning, and achievement of acceptable repeatability. Standard testing commonly requires at least 3 acceptable respiratory maneuvers, and variation between key measurements must remain limited for results to be considered reliable. Automated software can reduce operator dependence but cannot eliminate the importance of correct patient instruction. Manufacturers are therefore adding guided workflows, graphical coaching, automated quality grading, and error alerts to improve consistency across decentralized settings.

Interoperability creates another challenge because healthcare providers increasingly expect diagnostic systems to connect with hospital information systems, electronic medical records, and centralized data platforms. A large hospital may operate more than 10 diagnostic software systems, making integration an important procurement criterion. PFT manufacturers must support standardized data export, cybersecurity, user authentication, software upgrades, and compatibility with evolving healthcare IT infrastructure. Data transfer failures can increase manual entry and create workflow inefficiency. Smaller manufacturers may struggle to maintain broad integration capability across multiple hospital platforms. Through 2035, competitive success will increasingly depend on combining accurate pulmonary measurement with software interoperability, secure connectivity, automated quality assessment, and reliable technical support.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

By Types

Portable PFT Systems: Portable PFT Systems are estimated to hold approximately 36.7% of product demand in 2026 and represent the fastest-expanding equipment category. These systems are designed for outpatient clinics, Physician Groups, Physical Examination Center settings, occupational health programs, community screening, and other environments where permanent laboratory infrastructure is not practical. Devices weighing less than 5 kilograms can be moved easily between examination rooms and remote testing locations. Many systems support spirometry and selected additional measurements while offering wireless transfer, tablet connectivity, automated interpretation support, and electronic record integration. The segment is projected to approach approximately 41.5% share by 2035 as decentralized respiratory assessment becomes more common.

Complete PFT Systems: Complete PFT Systems dominate the market with approximately 58.4% share in 2026. These platforms are primarily used in Hospitals and specialist pulmonary centers where physicians require comprehensive respiratory assessment. Complete systems can measure more than 8 parameters, including spirometric values, lung volumes, diffusion capacity, respiratory pressures, and airway resistance depending on system configuration. Large facilities prefer integrated platforms because multiple measurements can be completed within a centralized workflow. Automated calibration, quality assurance, and software reporting are becoming increasingly important purchasing criteria. Although the segment will remain dominant through 2035, its proportional share is expected to gradually decline as portable solutions gain wider adoption in outpatient settings.

Other: Other pulmonary function testing products are estimated to represent approximately 4.9% of product demand in 2026. This category includes specialized respiratory measurement equipment and supplementary diagnostic systems used where conventional portable or complete platforms do not fully address clinical requirements. Specialized devices may support targeted measurements, research applications, exercise-based testing, or respiratory muscle assessment. Demand is comparatively limited but technically significant because some clinical environments require highly specific measurements. Products in this category can complete selected evaluations within approximately 10 minutes depending on the test protocol. Continued respiratory research and specialist clinical applications are expected to sustain a stable niche through 2035.

By Applications

Hospitals: Hospitals are expected to account for approximately 47.8% of global pulmonary function testing demand in 2026, making them the largest application category. Hospitals maintain centralized pulmonary laboratories, respiratory specialists, trained technicians, and high patient throughput, supporting adoption of Complete PFT Systems. Comprehensive assessments can involve more than 5 distinct physiological measurements during a single visit. Hospital testing is used for chronic respiratory disease evaluation, preoperative assessment, treatment monitoring, occupational referral, and specialist diagnosis. Large institutions may perform more than 30 pulmonary tests during a typical working day, increasing the importance of workflow automation, calibration reliability, and electronic medical record integration.

Physical Examination Center: Physical Examination Center applications account for approximately 18.6% of market demand in 2026. These facilities use pulmonary function testing for preventive health examinations, occupational screening, employee fitness assessments, and routine respiratory evaluation. Portable PFT Systems are particularly important because they can be deployed efficiently across high-throughput screening environments. Standard spirometry can often be completed within approximately 15 minutes, enabling multiple patients to be evaluated during scheduled examination sessions. Increasing corporate health programs and occupational respiratory surveillance are expected to support steady demand through 2035. Facilities conducting large-volume screening increasingly prioritize automated quality assessment and rapid digital reporting.

Physician Groups: Physician Groups are estimated to represent approximately 20.7% of pulmonary function testing demand in 2026. Pulmonology practices, primary-care groups, allergy clinics, and other outpatient specialists increasingly incorporate spirometry and basic pulmonary testing directly into clinical workflows. Portable systems enable practices to perform assessment without referring every patient to a hospital laboratory. A compact PFT device capable of processing approximately 4 patients per hour can support routine outpatient demand while limiting infrastructure requirements. Electronic record connectivity and automated interpretation tools are particularly valuable in Physician Groups because staff may have less specialized pulmonary laboratory training. The segment is expected to expand as decentralized diagnostics become more common.

Others: Others account for approximately 12.9% of application demand in 2026 and include specialized diagnostic, rehabilitation, occupational, academic, and research settings. These users may require either compact portable systems or technically advanced platforms depending on the testing objective. Pulmonary rehabilitation programs can use repeated testing at intervals of approximately 3 months to monitor respiratory progress and treatment response. Academic and research organizations may require detailed measurements beyond basic spirometry. Demand in this category is expected to remain diverse through 2035 as respiratory diagnostics become embedded across a wider range of preventive, rehabilitation, and research environments.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

North America

North America is expected to account for approximately 37.2% of global pulmonary function testing demand in 2026, making it the leading regional market. The region benefits from advanced hospital infrastructure, widespread specialist respiratory care, established pulmonary laboratories, and high adoption of digital diagnostic technologies. The United States accounts for approximately 74.6% of regional demand and remains the largest individual market. Hospitals represent close to 49.3% of U.S. utilization, reflecting strong dependence on comprehensive pulmonary laboratories. Portable PFT Systems are also gaining traction and account for approximately 38.5% of national equipment demand as outpatient respiratory testing expands.

Technology adoption is particularly strong across North American healthcare systems. Hospitals increasingly prioritize platforms capable of integrating more than 8 pulmonary measurements with electronic medical records and automated quality monitoring. Outpatient Physician Groups are expanding office-based spirometry, while occupational health programs increasingly incorporate portable respiratory testing. Standard examinations completed within approximately 15 minutes improve throughput in high-volume clinical settings. Through 2035, regional growth is expected to be driven by replacement of aging diagnostic systems, software upgrades, decentralized respiratory testing, and stronger adoption of connected portable devices.

Europe

Europe is estimated to account for approximately 28.4% of global pulmonary function testing demand in 2026. Germany, France, the United Kingdom, Italy, Switzerland, and other regional healthcare markets maintain strong pulmonary medicine infrastructure and specialist testing capacity. Complete PFT Systems represent approximately 60.2% of European equipment demand because many hospitals operate established pulmonary laboratories. Clinical emphasis on standardized respiratory assessment supports high usage of spirometry, diffusion measurements, and lung-volume testing. European institutions increasingly seek diagnostic systems capable of meeting repeatability criteria across at least 3 acceptable respiratory maneuvers.

Portable testing is becoming increasingly important as outpatient and community-based healthcare expands. Portable PFT Systems account for approximately 34.9% of regional demand and are gaining adoption among Physician Groups and Physical Examination Center users. European healthcare providers also emphasize software interoperability, data protection, calibration quality, and workflow integration. Systems capable of performing approximately 20 tests during a working day can improve efficiency in outpatient diagnostic settings. Through 2035, replacement demand, digital modernization, and increased outpatient respiratory screening are expected to sustain steady regional market development.

Asia-Pacific

Asia-Pacific is projected to be the fastest-growing regional market, expanding at approximately 5.8% annually through 2035. China, Japan, India, South Korea, and other regional economies are increasing hospital capacity, specialist respiratory services, occupational health screening, and diagnostic technology adoption. Hospitals currently represent approximately 45.2% of regional PFT utilization, while Physician Groups and Physical Examination Center settings are gaining importance. Portable PFT Systems account for approximately 39.8% of regional equipment demand in 2026 because compact devices can improve access in locations without dedicated pulmonary laboratories.

China and India offer substantial growth potential because large populations and expanding diagnostic networks create strong demand for affordable respiratory testing. Japan maintains a mature respiratory-care environment and contributes to advanced device adoption. Regional suppliers are increasingly introducing software-guided spirometry and compact systems capable of completing tests in approximately 15 minutes. Local manufacturing also supports more competitive equipment pricing. Through 2035, Asia-Pacific demand is expected to expand as diagnostic penetration improves and respiratory testing becomes more widely incorporated into hospital, outpatient, occupational, and preventive-care workflows.

Latin America

Latin America is estimated to account for approximately 8.6% of global pulmonary function testing demand in 2026. Brazil and Mexico represent major regional markets because of their established hospital systems, growing private healthcare sectors, and expanding respiratory diagnostic capacity. Hospitals account for approximately 46.4% of regional PFT utilization, while Physician Groups and Physical Examination Center applications are gradually increasing. Portable PFT Systems represent approximately 37.6% of regional equipment demand and are particularly attractive to outpatient clinics seeking lower infrastructure requirements.

Regional growth is supported by increasing adoption of preventive health examinations and respiratory screening. A portable system capable of evaluating approximately 4 patients per hour can offer practical economic advantages for outpatient facilities operating with limited staffing. Access to distributor training and equipment servicing remains important because measurement quality depends on correct calibration and patient coaching. Through 2035, gradual healthcare modernization, expansion of private diagnostic networks, and wider use of compact respiratory equipment are expected to support market development across major Latin American economies.

Middle East & Africa

Middle East & Africa is estimated to represent approximately 5.8% of global pulmonary function testing demand in 2026. Gulf countries are investing in modern hospital infrastructure and specialist respiratory services, while several African markets are gradually expanding access to diagnostic testing. Portable PFT Systems represent approximately 42.1% of regional equipment demand because they require less infrastructure than complete laboratory platforms. This makes portable devices particularly suitable for community screening, outpatient clinics, and geographically dispersed healthcare networks.

Resource limitations remain important because comprehensive systems require trained technicians, controlled laboratory environments, and ongoing maintenance. Portable systems that can operate with fewer than 10 minutes of setup time provide an attractive alternative for smaller facilities. Distributor training and local service availability are critical because device calibration and maintenance directly influence measurement reliability. Through 2035, regional growth is expected to be strongest in urban healthcare centers and countries increasing expenditure on respiratory diagnostics, occupational health, and preventive screening.

List of Top Pulmonary Function Testing Companies

• CareFusion (BD) (U.S.)
• Schiller (Switzerland)
• CHEST (Japan)
• COSMED (Italy)
• nSpire Health (U.S.)
• NDD (Switzerland)
• MGC Diagnostics (U.S.)
• Minato (Japan)
• Ganshorn (Germany)
• AESRI (China)
• Morgan Scientific (U.S.)
• M&B (China)
• Sikeda (China)
• RSDQ (China)

Top 2 Companies Market Share

CareFusion (BD): CareFusion (BD) is estimated to account for approximately 15.8% of organized pulmonary function testing equipment demand, supported by established respiratory diagnostic capabilities, broad hospital relationships, integrated clinical technology, and extensive technical service infrastructure. Its competitive position is strengthened by demand for Complete PFT Systems capable of supporting more than 8 respiratory measurements and integrating test data into broader hospital diagnostic workflows. Strong presence across North America also supports recurring demand from large healthcare institutions replacing or modernizing pulmonary laboratory equipment.

Schiller: Schiller is estimated to hold approximately 10.9% of organized PFT equipment demand, supported by respiratory diagnostic expertise, portable testing technologies, and a broad international distribution network. Portable systems represent approximately 36.7% of total market demand in 2026, creating favorable conditions for suppliers with compact and software-enabled products. The company's position across European and international healthcare systems is reinforced by demand for digital testing workflows, connectivity, and user-friendly diagnostic equipment suitable for hospitals and outpatient settings.

Investment Analysis

Investment in the Pulmonary Function Testing Market is increasingly directed toward portable systems, digital workflow integration, automated quality control, software analytics, and hospital equipment modernization. Complete PFT Systems account for approximately 58.4% of product demand in 2026, ensuring continued capital investment in centralized pulmonary laboratories. Hospitals upgrading equipment increasingly favor platforms capable of integrating more than 8 respiratory measurements into a single testing environment. Investment priorities include electronic medical record connectivity, automated calibration, disposable infection-control components, and cloud-based data management. Facilities conducting more than 25 tests daily can achieve meaningful workflow gains through automated reporting and reduced manual data entry.

Portable PFT Systems represent a particularly attractive investment area because their share is projected to increase from approximately 36.7% in 2026 to 41.5% by 2035. Manufacturers are investing in lighter hardware, wireless data transfer, simplified calibration, rechargeable power systems, automated coaching, and touchscreen interfaces. Asia-Pacific is also attracting increased investment because regional demand is projected to grow at approximately 5.8% annually. Local manufacturing and distribution partnerships can reduce equipment cost and improve service availability. Investment in software is becoming equally important because healthcare providers increasingly expect respiratory devices to communicate with broader digital health infrastructure.

New Product Development

New product development is focused on compact pulmonary testing platforms that combine portability with increasingly comprehensive diagnostic capability. Manufacturers are designing systems weighing less than 5 kilograms that can perform spirometry, respiratory pressure measurements, and selected additional tests while storing results electronically. Automated quality grading is becoming a core product feature because standard spirometry commonly requires at least 3 acceptable respiratory maneuvers for reliable interpretation. New platforms are using visual coaching, real-time error detection, and repeatability alerts to guide operators. Wireless connectivity and mobile-device interfaces are also becoming increasingly common as outpatient clinics and Physician Groups seek flexible diagnostic systems.

Complete PFT System development is concentrating on integrated respiratory laboratories capable of reducing test setup time and improving workflow efficiency. Advanced platforms can record more than 8 physiological parameters and automatically generate structured reports for clinician review. Manufacturers are also developing lower-maintenance sensors and more automated calibration routines to reduce technician workload. Disposable flow-measurement components are gaining attention because infection-control requirements remain important in high-throughput environments. Through 2035, product differentiation is expected to depend increasingly on measurement accuracy, software interoperability, automated quality assurance, compact hardware, and simplified user experience rather than standalone hardware capability.

Five Recent Developments

• March 2024: Pulmonary diagnostic manufacturers increased development of compact systems weighing below 5 kilograms, supporting broader use of Portable PFT Systems in outpatient clinics, Physician Groups, occupational screening, and community respiratory assessment.
• September 2024: PFT software development increasingly incorporated automated quality grading across at least 3 respiratory maneuvers, helping technicians identify inconsistent effort, repeatability problems, and incomplete patient performance during standard spirometry.
• April 2025: Hospital pulmonary laboratory upgrades focused increasingly on integrated systems capable of measuring more than 8 respiratory parameters within a unified software environment, improving workflow efficiency and centralizing diagnostic data management.
• November 2025: Manufacturers expanded wireless and electronic medical record connectivity across portable respiratory-testing platforms, enabling test data collected in approximately 15-minute examinations to move directly into broader digital clinical workflows.
• June 2026: Product development increasingly emphasized decentralized respiratory diagnostics, with Portable PFT Systems representing approximately 36.7% of equipment demand and manufacturers introducing compact platforms with automated coaching and simplified calibration.

Report Coverage

The Pulmonary Function Testing Market analysis covers the 2026 to 2035 forecast period using 2025 as the historical baseline and incorporates the stated 4.2% CAGR. Product analysis includes Portable PFT Systems, Complete PFT Systems, and Other, while application coverage includes Hospitals, Physical Examination Center, Physician Groups, and Others. Complete PFT Systems are identified as the leading product category with approximately 58.4% share in 2026, while Hospitals lead applications with approximately 47.8%. The assessment examines diagnostic workflow, portable testing adoption, digital integration, respiratory screening, automated quality control, equipment investment, regional expansion, competitive positioning, and product-development trends.

Regional coverage includes North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. North America is estimated to represent approximately 37.2% of global demand in 2026, while Asia-Pacific is projected to expand at approximately 5.8% annually through 2035. Competitive analysis covers CareFusion (BD), Schiller, CHEST, COSMED, nSpire Health, NDD, MGC Diagnostics, Minato, Ganshorn, AESRI, Morgan Scientific, M&B, Sikeda, and RSDQ. The report also evaluates portable devices below 5 kilograms, approximately 15-minute spirometry workflows, systems measuring more than 8 respiratory parameters, and the growing importance of software integration and automated test-quality management.